Castle Biosciences’ DecisionDx®-Melanoma Test Receives 2022 MedTech Breakthrough Award
Go back to Castle Biosciences’ DecisionDx®-Melanoma Test Receives 2022 MedTech Breakthrough Award| Castle Technologies, Inc. (NASDAQ: CSTL) | Delayed: 33.17 -0.27 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.44 | 52 Week High | $3.92 | |||
| Open | $33.36 | 52 Week Low | $0.00 | |||
| Day High | $34.73 | P/E | N/A | |||
| Day Low | $32.69 | EPS | $0.00 | |||
| Volume | 94,583 | |||||

